Abstract:The membrane-bound glycoprotein, amyloid precursor protein (APP), plays a central role in Alzheimer's disease (AD). The present paper investigates the neuritogenic-neurotoxic properties of this protein and relates them to possible aetiopathological mechanisms in AD. Marked differences in neuritic differentiation were detected when comparing untransfected tetraploid mouse neuroblastoma cells (or vector only cells) with transfected cells overexpressing APP(751). Transfected cells developed neurites quicker, and whereas all transfected cells differentiated, the degree of differentiation of untransfected cells was more variable. Fully differentiated transfected and untransfected cells had marked differences in neuritic morphology. Transfected cells had more neurites per cell, these being shorter and more branched than neurites on untransfected cells. The precocious differentiation of transfected cells was not maintained with neuritic process disintegration and cell death occurring from the seventh day onwards. Untransfected cells continued to extend their neuritic processes for up to five weeks. Membrane-associated forms of APP were responsible for these effects, rather than secreted APP or the beta/A4-peptide. Combined data from Western blot and immunocytochemical procedures showed a prominent accumulation of APP-C-terminal fragments in the perinuclear region, neuritic varicosities and growth cones of transfected cells, suggesting their involvement in the neuritogenic-neurotoxic process. Similar neuritogenic-neurotoxic mechanisms occurring in vivo, in association with compensatory synaptoplastic responses in the aged brain, may be part of the pathological process in AD.

Beta-Amyloid Precursor Protein (βapp) Processing in Alzheimer's Disease (AD) and Age-Related Macular Degeneration (AMD).

Progress in molecular mechanisms of β-amyloid peptides in alzheimer's disease

Functions of Amyloid Precursor Protein in Metabolic Diseases

Advances in the β-amyloid precursor protein of Alzheimer's disease

Proteolytic processing of Alzheimer's β-amyloid precursor protein.

Amyloid Precursor Protein Revisited

Biology and Pathophysiology of the Amyloid Precursor Protein

Cellular and Molecular Basis of Beta-Amyloid Precursor Protein Metabolism

Genetic Background Regulates Beta-Amyloid Precursor Protein Processing and Beta-Amyloid Deposition in the Mouse

Amyloid precursor protein-processing products affect mononuclear phagocyte activation: pathways for sAPP- and Abeta-mediated neurotoxicity.

The amyloid precursor protein: beyond amyloid

Amyloid Precursor Protein Revisited: NEURON-SPECIFIC EXPRESSION AND HIGHLY STABLE NATURE OF SOLUBLE DERIVATIVES

Neuritogenic-Neurotoxic Effects of Membrane-Associated Forms ofAmyloid Precursor Prot ein

Role of Amyloid -Peptide in the Pathogenesis of Age-Related Macular Degeneration

Amyloid precursor protein-processing products affect mononuclear phagocyte activation: pathways for sAPP- and Aβ-mediated neurotoxicity: Microglia-mediated oxidative neurotoxicity

Molecular and cellular mechanisms for Alzheimer's disease: understanding APP metabolism.

The Role of APP in Alzheimer’s Disease

The roles of amyloid precursor protein (APP) in neurogenesis: Implications to pathogenesis and therapy of Alzheimer disease.

The Enhancement Of Amyloid Precursor Protein And Beta-Site Amyloid Cleavage Enzyme 1 Interaction: Amyloid-Beta Production With Aging

Secretases Related to Amyloid Precursor Protein Processing

Targeting Amyloidogenic Processing of APP in Alzheimer’s Disease